Search

Author/Creator Multari, Andrea Giovanni

1. Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer. Issue 6 (July 2020)

Authors:
Roviello, Giandomenico; Conca, Raffaele; D'Angelo, Alberto; Multari, Andrea Giovanni; Paganini, Giovanni; Chiriacò, Giorgio; Petrioli, Roberto; Corona, Silvia Paola; Rosellini, Pietro; Aieta, Michele
Journal:
Anti-cancer drugs
Issue:
Volume 31:Issue 6(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study. Issue 20 (May 2018)

Authors:
Roviello, Giandomenico; Petrioli, Roberto; Nardone, Valerio; Rosellini, Pietro; Multari, Andrea Giovanni; Conca, Raffaele; Aieta, Michele
Other Names:
Zhang. Qinhong section editor.
Journal:
Medicine
Issue:
Volume 97:Issue 20(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials. (December 2016)

Authors:
Roviello, Giandomenico; Zanotti, Laura; Cappelletti, Maria Rosa; Gobbi, Angela; Borsella, Giulia; Pacifico, Chiara; Multari, Andrea Giovanni; Generali, Daniele
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 108(2016)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗